Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patterson

Showing results (1061-1070 of 1,160) with videos related to

Pageof 116
Sort By:
Current Eye Research|February 29, 2020
Interocular Symmetry of Foveal Cone Topography in Congenital AchromatopsiaKatie M Litts, Michalis Georgiou, Christopher S Langlo, et al.
Metabolic Syndrome and Related Disorders|January 2, 2014
Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the Longitudinal Assessment of Bariatric Surgery-2 studyJonathan Q Purnell, Faith Selzer, Mark D Smith, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
British Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
European Radiology|July 4, 2012
A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosisEdmund M Godfrey, Andrew J Patterson, Andrew N Priest, et al.
Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent p300/CBP InhibitorAnthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, et al.
Pageof 116

Showing results (1061-1070 of 1,160) with videos related to

Sort By:
Pageof 116
Current Eye Research|February 29, 2020
Interocular Symmetry of Foveal Cone Topography in Congenital AchromatopsiaKatie M Litts, Michalis Georgiou, Christopher S Langlo, et al.
Metabolic Syndrome and Related Disorders|January 2, 2014
Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the Longitudinal Assessment of Bariatric Surgery-2 studyJonathan Q Purnell, Faith Selzer, Mark D Smith, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
British Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
European Radiology|July 4, 2012
A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosisEdmund M Godfrey, Andrew J Patterson, Andrew N Priest, et al.
Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent p300/CBP InhibitorAnthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, et al.
Pageof 116